Bioorganic and Medicinal Chemistry p. 593 - 602 (1996)
Update date:2022-08-03
Topics:
Kuyper, Lee F.
Garvey, Janice M.
Baccanari, David P.
Champness, John N.
Stammers, David K.
Beddell, Christopher R.
Conformationally restricted analogues of the antibacterial agent trimethoprim (TMP) were designed to mimic the conformation of drug observed in its complex with bacterial dihydrofolate reductase (DHFR). This conformation of TMP was achieved by linking the 4-amino function to the methylene group by one-and two-carbon bridges. A pyrrolo[2,3-d]pyrimidine, a dihydro analogue, and a tetrahydropyrido[2,3-d]pyrimidine were synthesized and tested as inhibitors of DHFR. One analogue showed activity equivalent to that of TMP against DHFR from three species of bacteria. An X-ray crystal structure of this inhibitor bound to Escherichia coli DHFR was determined to evaluate the structural consequences of the conformational restriction. Copyright
View MoreContact:+86-15995924277
Address:WuZhongOu suzhou new south road 89
Beijing Harmony Chemical Co., Ltd.
Contact:86-010-84956928
Address:Room 207, Jin feng he B building, No 8 Xin Jie Kou Wai Street, Xi Cheng District, Beijing,PRC. 10008
Hubei Danao Pharmaceutical Co.,Ltd.
website:http://www.danaopharm.com
Contact:+86-719-5251167
Address:Fandan Road,Danjiangkou,Hubei
Yuan Shi(SuQian)Biotechnology Co.,Ltd
website:http://www.yuanshibio.com
Contact:+86-527-84226672
Address:jiangsu suqian
Contact:--
Address:80G, No.1 Building, Guodu Development Mansion, No. 182 Zhaohui Road, Hangzhou City, Zhejiang Province,China.
Doi:10.1021/ic9602052
(1996)Doi:10.1016/S0968-0896(96)00218-0
(1996)Doi:10.1021/jm001119l
(2001)Doi:10.1007/s10822-010-9371-3
(2010)Doi:10.1016/0040-4039(95)02300-3
(1996)Doi:10.1021/jm501827k
(2015)